Skip Navigation

Breast Cancer Clinical Trials and Research

  • New Patient Appointments
    877-442-3324

    Make Appointment Online
    Dana-Farber/Brigham and Women's Cencer Center logo
    US News adult badge - smaller

  • Clinical Trials Questions?

    877-DF-TRIAL
    (877-338-7425)

     

  • Dana-Farber's Eric P. Winer, MD, Explains Results of HER2CLIMB Trial
    This trial looks at a new breast cancer drug called tucatinib, combined with standard therapies. Results presented at SABCS 2019.